Acceso a Merck Medicus (gratis!)...

Inigualable acceso a diversas fuentes de información médica al alcance de todos, enumerar todos los recursos sería agotador!!..

Por este motivo les dejo a continuación el username y password:

User name: alfredp87
Password: externomedicina

Link:
http://www.merckmedicus.com/pp/us/hcp/hcp_home.jsp

Múltiples recursos académicos a través de MSD...

Hoy les comparto este excelente recurso académico médico, se trata de MSD (merck sharp & dohme) que ofrece trás registrarse de manera gratuita:

- Manuales Merck (17ma edición, Geriatría, Merck Index)
- Modelos Anatómicos 3D
- Manual 12 de Octubre
- Recursos para el paciente (Manual Merck para el Hogar, MEDLINEplus)
- Biblioteca Médica Digital Plus (Acceso a MD Consult)
- Información Científica de Especialidades Médicas (Anestesiología, Cardiología, Endocrinología, etc.)
- Cursos Online de Actualización Médica
- Acceso Harrison's Online


Link:
http://www.msd.com.ec/msdec/account/signin.html

Los 20 mas leidos...

Recientemente La revista "The Lancet" publico los 20 articulos mas leidos hasta el momento en este 2010...

A continuacion les dejo los links de los 20 articulos mas una sorpresa al final de los mismos...

1. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

2. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

3. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

4. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

5. Biological, clinical, and ethical advances of placebo effects

6. Clinical assessment incorporating a personal genome

7. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

8. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

9. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

10. Ticagrelor in ACS: redefining a new standard of care?

11. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial

12. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

13. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

14. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension

15. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

16. Ageing populations: the challenges ahead

17. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials

18. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

19. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

20. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

Clave The Lancet:
Username: ICSML2
Password: hammersmith